Potential Role of Lipophagy Impairment for Anticancer Effects of Glycolysis-Suppressed Pancreatic Ductal Adenocarcinoma Cells

By screening anticancer metabolic compounds, investigators identified an inhibitor of lysine-specific histone demethylase 1A, which dramatically decreased the growth of PDAC and showed an anti-tumoral effect in tumor-bearing mice.